Ambu A/S (OTCMKTS:AMBBY) Releases Earnings Results

Ambu A/S (OTCMKTS:AMBBY) announced its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, Zacks reports. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%. The company had revenue of $246.39 million during the quarter.

Ambu A/S Price Performance

OTCMKTS AMBBY remained flat at $9.98 during trading hours on Thursday. 600 shares of the company traded hands, compared to its average volume of 159. Ambu A/S has a one year low of $9.70 and a one year high of $16.78. The company has a market cap of $2.35 billion, a P/E ratio of 32.19 and a beta of 1.06. The company has a quick ratio of 1.67, a current ratio of 2.86 and a debt-to-equity ratio of 0.08. The company’s 50-day moving average is $10.91 and its 200-day moving average is $12.78.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.